ClearPoint Neuro to Present at the B. Riley Securities 2023 Institutional Investor Conference
ClearPoint Neuro (Nasdaq: CLPT), a global therapy-enabling platform company focused on brain navigation and delivery, has announced its participation in the B. Riley Securities 2023 Institutional Investor Conference. The company's management team is scheduled to present on Wednesday, May 24, 2023, at 8:15 a.m. Pacific Time.
This conference provides an opportunity for ClearPoint Neuro to showcase its innovative technologies and business strategies to institutional investors. As a leader in brain-focused therapies, the company's presentation is likely to generate significant interest among attendees and potential investors in the medical technology sector.
ClearPoint Neuro (Nasdaq: CLPT), un'azienda globale che offre piattaforme abilitanti per la terapia, focalizzata sulla navigazione e somministrazione cerebrale, ha annunciato la sua partecipazione alla Conferenza per Investitori Instituzionali 2023 di B. Riley Securities. Il team di gestione dell'azienda è programmato per presentare il mercoledì 24 maggio 2023, alle 8:15 ora del Pacifico.
Questa conferenza offre un'opportunità a ClearPoint Neuro di mettere in mostra le sue tecnologie innovative e le sue strategie aziendali agli investitori istituzionali. Essendo un leader nelle terapie focalizzate sul cervello, la presentazione dell'azienda è destinata a suscitare un interesse significativo tra i partecipanti e i potenziali investitori nel settore della tecnologia medica.
ClearPoint Neuro (Nasdaq: CLPT), una empresa global que ofrece plataformas habilitantes para terapia, enfocada en la navegación y entrega cerebral, ha anunciado su participación en la Conferencia de Inversores Institucionales 2023 de B. Riley Securities. El equipo de gestión de la empresa está programado para presentar el miércoles 24 de mayo de 2023, a las 8:15 a.m. Hora del Pacífico.
Esta conferencia brinda la oportunidad a ClearPoint Neuro de mostrar sus tecnologías innovadoras y estrategias comerciales a los inversores institucionales. Como líder en terapias enfocadas en el cerebro, se espera que la presentación de la empresa genere un interés significativo entre los asistentes y potenciales inversores en el sector de la tecnología médica.
ClearPoint Neuro (Nasdaq: CLPT)는 뇌 탐색 및 전달에 중점을 두고 있는 글로벌 치료 지원 플랫폼 기업으로, B. Riley Securities 2023 기관 투자자 회의에 참여할 것이라고 발표했습니다. 회사의 경영팀은 2023년 5월 24일 수요일 오전 8시 15분 태평양 표준시에 발표할 예정입니다.
이 회의는 ClearPoint Neuro가 혁신적인 기술과 비즈니스 전략을 기관 투자자에게 선보일 수 있는 기회를 제공합니다. 뇌 중심 치료의 선두주자로서, 회사의 발표는 참석자들과 의료 기술 부문의 잠재적 투자자들 사이에서 상당한 관심을 불러일으킬 것으로 예상됩니다.
ClearPoint Neuro (Nasdaq: CLPT), une entreprise mondiale spécialisée dans les plateformes permettant des thérapies et se concentrant sur la navigation et la délivrance cérébrale, a annoncé sa participation à la Conférence des Investisseurs Institutionnels 2023 de B. Riley Securities. L'équipe de direction de l'entreprise est prévue pour présenter le mercredi 24 mai 2023, à 8h15, heure du Pacifique.
Cette conférence offre à ClearPoint Neuro l'opportunité de mettre en avant ses technologies innovantes et ses stratégies commerciales auprès des investisseurs institutionnels. En tant que leader dans les thérapies axées sur le cerveau, la présentation de l'entreprise devrait susciter un intérêt significatif parmi les participants et les investisseurs potentiels dans le secteur de la technologie médicale.
ClearPoint Neuro (Nasdaq: CLPT), ein globales Therapiefähigkeitsplattformunternehmen, das sich auf die Gehirnnavigation und -abgabe konzentriert, hat seine Teilnahme an der B. Riley Securities 2023 Institutional Investor Conference bekannt gegeben. Das Management-Team des Unternehmens wird voraussichtlich am Mittwoch, den 24. Mai 2023, um 8:15 Uhr pazifischer Zeit präsentieren.
Diese Konferenz bietet ClearPoint Neuro die Möglichkeit, seine innovativen Technologien und Geschäftstrategien institutionellen Investoren vorzustellen. Als führendes Unternehmen im Bereich der gehirnorientierten Therapien wird erwartet, dass die Präsentation des Unternehmens erhebliches Interesse bei den Teilnehmern und potenziellen Investoren im Bereich der Medizintechnologie weckt.
- None.
- None.
SOLANA BEACH, Calif., May 18, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, announced today that its management will present at the B. Riley Securities 2023 Institutional Investor Conference on Wednesday, May 24, 2023 at 8:15 a.m. Pacific Time.
About ClearPoint Neuro
ClearPoint Neuro’s mission is to improve and restore quality of life to patients and their families by enabling therapies for the most complex neurological disorders with pinpoint accuracy. Applications of the Company’s current product portfolio include deep brain stimulation, laser ablation, biopsy, and delivery of drugs, biologics, and gene therapy to the brain. The ClearPoint Neuro Navigation System has FDA clearance, is CE-marked, and is installed in over 65 active sites in the North America, Europe, and South America. ClearPoint Neuro is partnered with more than 50 pharmaceutical/biotech companies, academic centers, and contract research organizations providing solutions for direct CNS delivery of therapeutics in pre-clinical studies and clinical trials worldwide. To date, more than 6,000 procedures have been performed and supported by the Company’s field-based clinical specialist team, which offers support and services to our customers and partners worldwide. For more information, please visit www.clearpointneuro.com.
ClearPoint Neuro Contact:
Danilo D’Alessandro, Chief Financial Officer
(949)-900-6833
info@clearpointneuro.com
Caroline Corner, Investor Relations
ir@clearpointneuro.com
FAQ
When is ClearPoint Neuro (CLPT) presenting at the B. Riley Securities 2023 Institutional Investor Conference?
What does ClearPoint Neuro (CLPT) specialize in?
Where is the B. Riley Securities 2023 Institutional Investor Conference being held?
What is the significance of ClearPoint Neuro (CLPT) presenting at this conference?
